RG
REGENXBIO
RGNX·NASDAQRockville MDFounded 2009300 employees
Small CapbiotechPublicOphthalmologyNeurology
Platform: NAV AAV
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
1
Stock Price & Catalysts (RGNX)
Loading RGNX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| RGN-9803 | RGN-9803 | NDA/BLA | 2 | RET | SLESCD | ||
| Talazasiran | RGN-7746 | Approved | 1 | PLK4 | ADPKDAS |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)